Bone Support

Share Price

BONEX 288.80 SEK

-0.41%

18:00:00 CET Fri May 09 2025

  • Contact Us
Follow
  • US site
    • Global English Site
    • Global Swedish Site
    • US site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Sustainability
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® BONE VOID FILLER
    • CERAMENT® G with Gentamicin
    • Reimbursement Programs
    • OPTIONAL DELIVERY DEVICES
  • Innovation
    • Current Technology
    • Pipeline
    • CERTiFy Clinical Trial
  • Indications
  • Medical Professionals
  • Investors
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Events
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
    • Media Archive
  • Financials
  • Financial Reports
  • Presentations
  • The Share
  • Analyst Coverage
  • Shareholders
  • Corporate Governance
  • Calendar
  • Q&A
  • Definitions
  • Capital Markets Day 2022
  • CAPITAL MARKETS DAY 2023

Financial Reports 2017

BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017.

PDF Icon

Annual Report 2017

30/04/2018

PDF Icon

Full Year Report 2017

20/02/2018

Net sales amounted to SEK 129.3 million (13.4), an increase of 24%. Gross margin 87.0 % (84.4%). Operating loss of SEK -99.3 million (-10.3).
PDF Icon

Interim Report, Q3, July - September 2017

02/11/2017

Net sales amounted to SEK 32.7 million (26.5), an increase of 23%. Gross margin 87.8% (79.2). Operating loss of SEK -20.1 million (-25.9).
PDF Icon

Interim Report, Q2, April - June 2017

17/08/2017

Net sales amounted to SEK 37.1 million (25.2), an increase of 48%. Gross margin 87.2% (86.1). Operating loss of SEK -18.4 million (-20.8).
PDF Icon

Interim Report, Q1, January - March 2017

21/04/2017

Net Sales amounted to SEK 32.5 million (23.3), an increase of 40%. Gross margin of 88.8% (84.2). Operating loss of SEK -27.4 million (-13.7).

©BONESUPPORT AB 2025. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy